ROCKWELL MEDICAL, INC. 8-K

What Happened

• Rockwell Medical, Inc. announced its financial results for the quarter ended March 31, 2026 via a press release issued on May 7, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K under Item 2.02 (Results of Operations and Financial Condition). The filing also includes an Inline XBRL cover page as Exhibit 101.

Key Details

• Date of announcement: May 7, 2026. Period covered: quarter ended March 31, 2026.
• Filing: Form 8-K Item 2.02 (results of operations); press release furnished as Exhibit 99.1.
• Technical exhibit: Exhibit 101 — Inline XBRL cover page included in the filing.
• The Form 8-K furnishes the press release; investors should review Exhibit 99.1 for specific financial figures (revenue, net income/loss, cash position, and any commentary or guidance).

Why It Matters

• This filing provides the company’s most recent quarterly results and related commentary; those results can affect near-term investor decisions and the market’s view of Rockwell Medical’s performance.
• Because the Form 8-K furnishes the press release (and does not itself include detailed financial tables in-line), investors should read the press release and the company’s subsequent SEC reports (e.g., Form 10-Q) for full financial details and disclosures.